TY - JOUR
T1 - A high protein diet is more effective in improving insulin resistance and glycemic variability compared to a mediterranean diet—a cross-over controlled inpatient dietary study
AU - Tettamanzi, Francesca
AU - Bagnardi, Vincenzo
AU - Louca, Panayiotis
AU - Nogal, Ana
AU - Monti, Gianna Serafina
AU - Mambrini, Sara P.
AU - Lucchetti, Elisa
AU - Maestrini, Sabrina
AU - Mazza, Silvia
AU - Rodriguez-Mateos, Ana
AU - Scacchi, Massimo
AU - Valdes, Ana M.
AU - Invitti, Cecilia
AU - Menni, Cristina
N1 - Funding Information:
Funding: This work is funded by the NIHR Nottingham BRC. C.M., A.N. and P.L. are funded by the Chronic Disease Research Foundation. AMV is supported by the National Institute for Health Research Nottingham Biomedical Research Centre.
Publisher Copyright:
© 2021, MDPI. All rights reserved.
PY - 2021/12
Y1 - 2021/12
N2 - The optimal dietary pattern to improve metabolic function remains elusive. In a 21-day randomized controlled inpatient crossover feeding trial of 20 insulin-resistant obese women, we assessed the extent to which two isocaloric dietary interventions—Mediterranean (M) and high protein (HP)—improved metabolic parameters. Obese women were assigned to one of the following dietary sequences: M–HP or HP–M. Cardiometabolic parameters, body weight, glucose monitoring and gut microbiome composition were assessed. Sixteen women completed the study. Compared to the M diet, the HP diet was more effective in (i) reducing insulin resistance (insulin: Beta (95% CI) = −6.98 (−12.30, −1.65) µIU/mL, p = 0.01; HOMA-IR: −1.78 (95% CI: −3.03, −0.52), p = 9 × 10−3 ); and (ii) improving glycemic variability (−3.13 (−4.60, −1.67) mg/dL, p = 4 × 10−4 ), a risk factor for T2D development. We then identified a panel of 10 microbial genera predictive of the difference in glycemic variability between the two diets. These include the genera Coprococcus and Lachnoclostridium, previously associated with glucose homeostasis and insulin resistance. Our results suggest that morbidly obese women with insulin resistance can achieve better control of insulin resistance and glycemic variability on a high HP diet compared to an M diet.
AB - The optimal dietary pattern to improve metabolic function remains elusive. In a 21-day randomized controlled inpatient crossover feeding trial of 20 insulin-resistant obese women, we assessed the extent to which two isocaloric dietary interventions—Mediterranean (M) and high protein (HP)—improved metabolic parameters. Obese women were assigned to one of the following dietary sequences: M–HP or HP–M. Cardiometabolic parameters, body weight, glucose monitoring and gut microbiome composition were assessed. Sixteen women completed the study. Compared to the M diet, the HP diet was more effective in (i) reducing insulin resistance (insulin: Beta (95% CI) = −6.98 (−12.30, −1.65) µIU/mL, p = 0.01; HOMA-IR: −1.78 (95% CI: −3.03, −0.52), p = 9 × 10−3 ); and (ii) improving glycemic variability (−3.13 (−4.60, −1.67) mg/dL, p = 4 × 10−4 ), a risk factor for T2D development. We then identified a panel of 10 microbial genera predictive of the difference in glycemic variability between the two diets. These include the genera Coprococcus and Lachnoclostridium, previously associated with glucose homeostasis and insulin resistance. Our results suggest that morbidly obese women with insulin resistance can achieve better control of insulin resistance and glycemic variability on a high HP diet compared to an M diet.
KW - Dietary intervention
KW - Glycemic variability
KW - Gut microbiome
KW - High protein diet
KW - Insulin resistance
KW - Mediterranean diet
KW - Obesity
UR - http://www.scopus.com/inward/record.url?scp=85120639817&partnerID=8YFLogxK
U2 - 10.3390/nu13124380
DO - 10.3390/nu13124380
M3 - Article
AN - SCOPUS:85120639817
SN - 2072-6643
VL - 13
JO - Nutrients
JF - Nutrients
IS - 12
M1 - 4380
ER -